Rifaximin in cirrhosis: Is its microbiological spotless record under threat? [0.03%]
利福昔明在肝硬化中的应用：其无菌的记录受到威胁了吗？
Cornelius Engelmann
Cornelius Engelmann
Panu K Luukkonen
Panu K Luukkonen
All-cause and cause-specific mortality in patients with chronic hepatitis B and concurrent steatotic liver disease [0.03%]
慢性乙型肝炎并发脂肪肝患者的全因及病因特异性死亡率
Shang-Chin Huang,Tung-Hung Su,Tai-Chung Tseng et al.
Shang-Chin Huang et al.
Background & aims: Steatotic liver disease (SLD) is prevalent among patients with chronic hepatitis B (CHB). However, the effects of metabolic dysfunction-associated SLD (MASLD) on the long-term survival of such patients ...
Impact of metabolism-disrupting chemicals and folic acid supplementation on liver injury and steatosis in mother-child pairs [0.03%]
干扰代谢的化学物质及叶酸补充对母子肝损伤和脂肪变性的影响
Sandra India-Aldana,Vishal Midya,Larissa Betanzos-Robledo et al.
Sandra India-Aldana et al.
Background and aims: Scarce knowledge about the impact of metabolism-disrupting chemicals (MDCs) on steatotic liver disease limits opportunities for intervention. We evaluated pregnancy MDC-mixture associations with liver...
A new generation of non-invasive tests of liver fibrosis with improved accuracy in MASLD [0.03%]
新一代非侵入性肝纤维化检测在代谢相关脂肪肝疾病中的应用及其准确性提高
Paul Calès,Clémence M Canivet,Charlotte Costentin et al.
Paul Calès et al.
Background & aims: The accuracy of non-invasive tests (NITs) should be ≥80% (EASL recommendation). We aimed to compare the accuracies of the recommended NITs for advanced fibrosis in MASLD and improve NIT accuracy. ...
Impaired whole blood thrombin generation is associated with procedure-related bleeding in acutely decompensated cirrhosis [0.03%]
肝脱代偿急性期患者行内镜或介入治疗相关出血与全血凝血酶生成障碍有关
Alberto Zanetto,Elena Campello,Cristiana Bulato et al.
Alberto Zanetto et al.
Background & aims: The clinical utility of thrombomodulin-modified thrombin generation (TM-TG) in cirrhosis is uncertain. We conducted a prospective study to evaluate the prognostic value of TM-TG in cirrhosis. ...
Gut bacterial membrane components as pathogenic signalling molecules in PSC-IBD [0.03%]
肠道细菌膜组分在PSC-IBD中的病原信号分子作用机制研究
David C Trampert
David C Trampert
Sedoanalgesia During TIPS Placement: Balancing Comfort and Safety in Diverse Clinical Settings [0.03%]
经颈静脉肝内门体分流术放置期间的塞多 analgesia：在不同临床设置中平衡舒适和安全
Yong Lv,Zhengyu Wang,Bohan Luo et al.
Yong Lv et al.
Tianyuan Yang,Tong Bu,Bingqing Yang et al.
Tianyuan Yang et al.
A read-through circular RNA RCRIN inhibits metabolic dysfunction-associated steatotic liver disease [0.03%]
读图的圆环RNA RCRIN可抑制代谢紊乱相关性肝脂肪变性疾病
Yanying Wang,Jianyi Wang,Ziheng Zhou et al.
Yanying Wang et al.
Background & aims: The molecular mechanism underlying metabolic dysfunction-associated steatotic liver disease (MASLD) is elusive and whether non-coding RNAs can serve as biomarkers and therapeutic targets of MASLD is les...